Seroprevalence of Toxoplasmosis among Women Referring to Shahid Beheshti Hospital, Hamadan, Iran
Novelty in Biomedicine,
Vol. 3 No. 1 (2015),
1 February 2015
,
Page 1-5
https://doi.org/10.22037/nbm.v3i1.7409
Abstract
Background: Toxoplasmosis is a parasitic disease caused by the protozoan Toxoplasma gondii. The aim of this study was investigate the prevalence of toxoplasmosis among young women who referred to check up for toxoplasmosis attended in Shahid Beheshti hospital, Hamadan during 2013-2014.Materials and Methods: This study was performed on 2523 pregnant women who referred to laboratory of Shahid Beheshti hospital in Hamadan province (western of Iran) during 2013-2014. Age, level of education and place of residence were recorded in the relevant forms. Antibodies serum levels for all samples were examined by ELISA. IgG titer equals and more than 1:200 was presumed as seropositive. Data were analyzed using by SPSS version 19.0 software.
Results: 26.1% of IgG seropositive persons were city residents while 32.3% of them lived at village and suburb of city. 1.4% and 1.1% of at risk persons (based on IgG titration) were city and village residents, respectively. 1.3% and 1.9% of IgM seropositives were city and village residents, respectively. The percentage of at risk persons of city and village (based on IgM titration) were 0.3% and 0.6%, in a row. 29.7% of IgG seropositives did not have academic education while 30.4% of them graduated from high school, at least. The seropositive IgM percentage of non-academic educated persons and graduated/academic ones were 1.7% and 1.4%, respectively.
Conclusion: Our funding indicates the association between age of women and their level of education with percentage of contamination and prevalence. IgM seropositive is lesser than IgG. It means that toxoplasmosis is chronic or there is previous contact. To avoid the risk of toxoplasmosis infection particularly in pregnant women should be examined and the necessary preventive measures and training for young women should be presented.
- Toxoplasmosis
- Pregnant women
- Hamadan
How to Cite
References
Ayatollahi J, Sharifi M, Dehghani R, Melat A. Toxoplasmosis in pregnancy. J Shahid Sadoughi Univ Med Sci. 2011;19:257-65. [Persian]
Akyar I. Seroprevalence and Coinfections of Toxoplasma gondii in Childbearing Age Women in Turkey. Iran J Public Health. 2011;40:63-7.
Ertug S, Okyay P, Turkmen M, Yuksel H. Seroprevalence and risk factors for Toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health. 2005;5:66.
Fallah M, Rabiee S, Matini M, Taherkhani H. Seroepidemiology of toxoplasmosis in primigravida women in Hamadan, Islamic Republic of Iran, 2004. East Mediterr Health J. 2008;14:163-71.
Vaz RS, Thomaz-Soccol V, Sumikawa E, Guimarães ATB. Serological prevalence of Toxoplasma gondii antibodies in pregnant women from Southern Brazil. Parasitol Res. 2010;106:661-5.
Kaul R, Chen P, Binder SR. Detection of immunoglobulin M antibodies specific for Toxoplasma gondii with increased selectivity for recently acquired infections. J Clin Microbiol. 2004;42:5705-9.
Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol. 2001;15:357-65.
Nowakowska D, Stray-Pedersen B, Spiewak E, Sobala W, Małafiej E, Wilczyński J. Prevalence and estimated incidence of Toxoplasma infection among pregnant women in Poland: a decreasing trend in the younger population. Clin Microbiol Infect. 2006;12:913-7.
Alvarado-Esquivel C, Sifuentes-Alvarez A, Narro-Duarte SG, Estrada-Martínez S, Díaz-García JH, Liesenfeld O, et al. Seroepidemiology of Toxoplasma gondii infection in pregnant women in a public hospital in northern Mexico. BMC Infect Dis. 2006;6:113.
Jones JL, Kruszon-Moran D, Wilson M. Toxoplasma gondii infection in the United States, 1999–2000. Emerg Infect Dis. 2003;9:1371.
Robert-Gangneux F, Dardé M-L. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25:264-96.
Assmar M, Amirkhani A, Piazak N, Hovanesian A, Kooloobandi A, Etessami R. Toxoplasmosis in Iran. Results of a seroepidemiological study. Bull Soc Pathol Exot. 1997;90:19-21.
Kasper LH. Toxoplasma infections. In: Fauci AS , Braunwald E, Kasper DL, Hauser SL. Harrisons principles of internal medicine. 17th ed. New York: McGraw-Hill. 2008.
Gratzl R, Hayde M, Kohlhauser C, Herman M, Bwda G, Strobl W, et al. Follow-up of infants with congenital toxoplasmosis detected by polymerase chain reaction analysis of amniotic fluid. Eur J Clin Microbiol Infect Dis. 1998;17:853-8.
Foulon W, Pinon J, Stray-Pedersen B. Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am J Obstet Gynecol. 1999;181:843-7.
Gilbert RE, Peckham CS. Congenital toxoplasmosis in the United Kingdom: to screen or not to screen? J Med Screen. 2002;9:135-41.
Boyer K, Holfels E, Roizen N, Swisher C, Mack D, Remington J, et al. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal management and screening. Am J Obstet Gynecol. 2005;192:564-71.
Derouin F, Jacqz-Aigrain E, Thulliez P, Couvreur J, Leport C. Cotrimoxazole for prenatal treatment of congenital toxoplasmosis? Parasitol Today. 2000;16:254-6.
The Syrocot (Systematic Review on Congenital Toxoplasmosis) Study Group. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients’ data. Obstet Gynecol Surv. 2007;62:302-4.
Gilbert RE, Gras L, Wallon M, Peyron F, Ades AE, Dunn DT. Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 other-child pairs in Lyon, France. Int J Epidemiol. 2001;30:1303-8.
Gratzl R, Sodeck G, Platzer P, Jäger W, Graf J, Pollak A, et al. Treatment of toxoplasmosis in pregnancy: concentrations of spiramycin and neospiramycin in maternal serum and amniotic fluid. Eur J Clin Microbiol Infect Dis. 2002;21:12–6.
Dastan K, Asmar M, Motavalian A, Jalali J, Massiha A. Comparison of agglutination and indirect immuno-fluorescence methods in the diagnosis of toxoplasmosis. Tashkhis. 2006;47:18-21. [Persian]
Saffar M, Ajami A, Moslemi zadeh N. Prevalence of Toxoplasma gondi in pregnancy in Sari 1376-1377. J Mazandaran Univ Med Sci.1999;9:1-5. [Persian]
Mostafavi SN, Jalali monfared L. Systematic review of published studies on the epidemiology of toxoplasmosis in Iran. J Isfahan Med School. 2012;30:74-88. [Persian]
Fallah M. Matini M. Taherkhani H. Rabiei S. Hajiloei M. Seroepidemiology of toxoplasmosis among Pregnant Women in Hamadan City. Sci J Hamadan Uni Med Sci. 2006;13:33-37. [Persian]
Cheraghipour K, Taherkhani H, Fallah M, Sheikhan A, Srdaryan K, Rostami Nezhad M, et al. Seroprevalence of anti-Toxoplasma IgG and IgM antibodies in pregnant women referring to health centers of Khorramabad city. Sci J Hamadan Univ Med Sci. 2010;17:46-51. [Persian]
- Abstract Viewed: 765 times
- PDF Downloaded: 348 times